CymaBay Therapeutics

-$0.20 (-3.96%) As of 5:14 PM UTC today

Why Robinhood?

You can buy or sell CBAY and other stocks, options, and ETFs commission-free!

About CBAY

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products pipeline include Seladelpar, MBX-2982, CB-0406, and CB-001.

CEO
Sujal Shah
Employees
41
Headquarters
Newark, California
Founded
1988

CBAY Key Statistics

Market Cap
326.01M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
907.04K
High Today
$4.89
Low Today
$4.68
Open Price
$4.87
Volume
293.30K
52 Week High
$9.06
52 Week Low
$3.16

CBAY Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure